![Jason Stein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Stein
Oprichter bij Actin Biomed LLC
Actieve functies van Jason Stein
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Actin Capital LLC | Corporate Officer/Principal | 01-12-2006 | - |
Cutanea Life Sciences, Inc.
![]() Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA. | Directeur/Bestuurslid | 01-06-2004 | - |
Actin Biomed LLC
![]() Actin Biomed LLC Investment ManagersFinance Founded in 2006 by Michael Weiser and Jason Stein, Actin Biomed LLC is a venture capital firm located in New York City. | Voorzitter | 01-12-2006 | - |
Oprichter | 21-07-2011 | - | |
Private Equity Investor | 01-12-2006 | - |
Loopbaan van Jason Stein
Eerdere bekende functies van Jason Stein
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Directeur/Bestuurslid | 01-06-2004 | 08-02-2008 |
Ivory Capital Corp. | Directeur/Bestuurslid | - | 02-08-2005 |
Foresight Biotherapeutics, Inc.
![]() Foresight Biotherapeutics, Inc. BiotechnologyHealth Technology Foresight Biotherapeutics, Inc. develops drugs and therapies for diseases of the eyes and ears. It offers FST-100 (topical ophthalmic drops combining povidone iodine and dexamethasone), a therapy in late-stage development for the treatment of infectious conjunctivitis, an ocular surface condition commonly referred to as pink eye. The company was founded by Jason Stein and Michael Weiser on September 4, 2008 and is headquartered in New York, NY. | Directeur/Bestuurslid | 04-09-2008 | - |
Oprichter | 04-09-2008 | - | |
Velcera LLC
![]() Velcera LLC Pharmaceuticals: MajorHealth Technology Velcera LLC operates as a pharmaceutical company. It focuses on innovation in the expanding pet health market and its product development targets pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. The firm is developing Promist, a transmucosal oral mist drug delivery technology for use in companion animals. It is also developing Promist products, including VEL504 for pain management and VEL502 for treating allergic atopic dermatitis in canines. The company was founded ion February 18, 2010 and is headquartered in Yardley, PA. | Directeur/Bestuurslid | 01-05-2004 | - |
Opleiding van Jason Stein
University of Michigan | Undergraduate Degree |
Saba University School of Medicine BV | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Canada | 2 |
2 |
Operationeel
Director/Board Member | 5 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Finance | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
Ivory Capital Corp. | Finance |
Chelsea Therapeutics International Ltd.
![]() Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Actin Capital LLC | |
Cutanea Life Sciences, Inc.
![]() Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA. | Health Technology |
Velcera LLC
![]() Velcera LLC Pharmaceuticals: MajorHealth Technology Velcera LLC operates as a pharmaceutical company. It focuses on innovation in the expanding pet health market and its product development targets pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. The firm is developing Promist, a transmucosal oral mist drug delivery technology for use in companion animals. It is also developing Promist products, including VEL504 for pain management and VEL502 for treating allergic atopic dermatitis in canines. The company was founded ion February 18, 2010 and is headquartered in Yardley, PA. | Health Technology |
Actin Biomed LLC
![]() Actin Biomed LLC Investment ManagersFinance Founded in 2006 by Michael Weiser and Jason Stein, Actin Biomed LLC is a venture capital firm located in New York City. | Finance |
Foresight Biotherapeutics, Inc.
![]() Foresight Biotherapeutics, Inc. BiotechnologyHealth Technology Foresight Biotherapeutics, Inc. develops drugs and therapies for diseases of the eyes and ears. It offers FST-100 (topical ophthalmic drops combining povidone iodine and dexamethasone), a therapy in late-stage development for the treatment of infectious conjunctivitis, an ocular surface condition commonly referred to as pink eye. The company was founded by Jason Stein and Michael Weiser on September 4, 2008 and is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- Jason Stein
- Ervaring